39. Maturitas. 2018 Apr;110:62-70. doi: 10.1016/j.maturitas.2018.01.020. Epub 2018Jan 31.Meat intake, methods and degrees of cooking and breast cancer risk in theMCC-Spain study.Boldo E(1), Castelló A(2), Aragonés N(3), Amiano P(4), Pérez-Gómez B(5),Castaño-Vinyals G(6), Martín V(7), Guevara M(8), Urtiaga C(9), Dierssen-SotosT(10), Fernández-Tardón G(11), Moreno V(12), Solans M(13), Peiró R(14), CapeloR(15), Gómez-Acebo I(16), Castilla J(17), Molina AJ(18), Castells X(19), AltzibarJM(20), Lope V(21), Kogevinas M(22), Romieu I(23), Pollán M(24); MCC-Spainresearchers.Author information: (1)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:eiboldo@isciii.es.(2)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:acastello@isciii.es.(3)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:naragones@isciii.es.(4)Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Public Health Division of Gipuzkoa, BioDonostia Research Institute, Paseo DrBeguiristain s/n, 20014 San Sebastian, Spain. Electronic address:epicss-san@ej-gv.es.(5)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:bperez@isciii.es.(6)Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Carrer delDoctor Aiguader 88, 08003 Barcelona, Spain; IMIM (Hospital del Mar MedicalResearch Institute), Carrer del Doctor Aiguader 88, 08003 Barcelona, Spain;Universitat Pompeu Fabra (UPF), Plaça de la Mercè, 10, 08002 Barcelona, Spain.Electronic address: gemma.castano@isglobal.org.(7)Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Instituto de Biomedicina (IBIOMED), Grupo de Investigación en InteraccionesGen-Ambiente y Salud, Universidad de León, Campus Vegazana, s/n, 24071 León,Spain. Electronic address: vicente.martin@unileon.es.(8)Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Early Detection Section, Public Health Institute of Navarre, IdiSNA,C/Irunlarrea, 3, 31008 Pamplona, Spain. Electronic address:mguevare@cfnavarra.es.(9)Public Health Division of Gipuzkoa, BioDonostia Research Institute, Paseo DrBeguiristain s/n, 20014 San Sebastian, Spain. Electronic address:c-urtiaga@ej-gv.es.(10)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Universidad de Cantabria - IDIVAL, Avenida Cardenal Herrera Orias/n, 39011 Santander, Spain. Electronic address: dierssent@unican.es.(11)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Instituto Universitario de Oncología IUOPA, University of Oviedo, Facultad de Medicina, Planta 7, Campus de El Cristo B, 33006, Oviedo, Spain.Electronic address: gfernanta@gmail.com.(12)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Cancer Prevention and Control Program, Catalan Institute ofOncology (ICO), IDIBELL, Gran Via, 199-203, 08907, L'Hospitalet de Llobregat,Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine,University of Barcelona, Campus de Bellvitge, Pavelló de Govern, Feixa Llargas/n, 08907, Barcelona, L'Hospitalet del Llobregat, Spain. Electronic address:v.moreno@iconcologia.net.(13)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Research Group on Statistics, Econometrics and Health (GRECS),Universitat de Girona, Campus Montilivi, 17071 Girona, Spain; Epidemiology Unitand Girona Cancer Registry, Oncology Coordination Plan, Department of Health,Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.Electronic address: martasolans@gmail.com.(14)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Fundación para el Fomento de la Investigación Sanitaria yBiomédica de la Comunitat Valenciana FISABIO-Salud Pública, Valencia. Avda.Cataluña, 21, 46020, Valencia, Spain. Electronic address: peiro_ros@gva.es.(15)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Centre for Research in Health and Environment (CYSMA), Universidadde Huelva, Campus Universitario de El Carmen, 21071, Huelva, Spain. Electronicaddress: rocio.capelo@dbasp.uhu.es.(16)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Universidad de Cantabria - IDIVAL, Avenida Cardenal Herrera Orias/n, 39011 Santander, Spain. Electronic address: ines.gomez@unican.es.(17)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Early Detection Section, Public Health Institute of Navarre,IdiSNA, C/Irunlarrea, 3, 31008 Pamplona, Spain. Electronic address:jesus.castilla.catalan@cfnavarra.es.(18)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Instituto de Biomedicina (IBIOMED), Grupo de Investigación enInteracciones Gen-Ambiente y Salud, Universidad de León, Campus Vegazana, s/n,24071 León, Spain. Electronic address: ajmolt@unileon.es.(19)Departments of Epidemiology and Evaluation-IMIM (Hospital del Mar MedicalResearch Institute), Carrer del Doctor Aiguader 88, 08003, Barcelona, Spain;Research Network on Health Services in Chronic Diseases (REDISSEC), Carrer delDoctor Aiguader 88, 08003, Barcelona, Spain; Universitat Autonoma de Barcelona,Av. Universitat Autònoma, 20, 08290 Cerdanyola del Vallès, Barcelona, Spain.Electronic address: XCastells@parcdesalutmar.cat.(20)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; Breast Cancer Screening Program, Osakidetza-Health Basque RegionService, Avenida Navarra, 4, 20013, San Sebastián, Spain. Electronic address:JONEMIREN.ALTZIBARAROTZENA@osakidetza.eus.(21)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology,Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:vicarvajal@isciii.es.(22)Consortium for Biomedical Research in Epidemiology & Public Health(CIBERESP), Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029Madrid, Spain; ISGlobal, Centre for Research in Environmental Epidemiology(CREAL), Carrer del Doctor Aiguader 88, 08003 Barcelona, Spain; IMIM (Hospitaldel Mar Medical Research Institute), Carrer del Doctor Aiguader 88, 08003Barcelona, Spain; Universitat Pompeu Fabra (UPF), Plaça de la Mercè, 10, 08002Barcelona, Spain. Electronic address: manolis.kogevinas@isglobal.org.(23)Nutrition and Metabolism Section, International Agency for Research onCancer, 150 Cours Albert Thomas, 69372 Lyon, France. Electronic address:romieui@iarc.fr.(24)Cancer and Environmental Epidemiology Unit, National Centre for Epidemiology,Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Consortium for Biomedical Research in Epidemiology & Public Health (CIBERESP),Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain;Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta deHierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain. Electronic address:mpollan@isciii.es.OBJECTIVE: To analyse the relationship of the risk of breast cancer (BC) to meat intake, preference regarding degree of cooking ('doneness') and cooking methods, using data from a population-based case-control study (MCC-Spain).STUDY DESIGN: 1006 Histologically confirmed incident BC cases and 1370 controlswere recruited in 10 Spanish provinces. Participants were 23-85 years old. Theyanswered an epidemiological survey and a food frequency questionnaire. BC riskwas assessed overall, by menopausal status and by pathological subtypes, usinglogistic and multinomial regression mixed models adjusted for known confoundingfactors and including province as a random effects term.MAIN OUTCOME MEASURES: Breast cancer and pathological subtype.RESULTS: High total intake of meat (ORQ4-Q1 (95% IC) = 1.39 (1.03-1.88)) wasassociated with increased BC risk among post-menopausal women. Similar resultswere found for processed/cured meat (ORQ4-Q1 (95% IC) = 1.47 (1.10-1.97)), andthis association was particularly strong for triple-negative tumours (ER-, PR-and HER2-) (ORQ4-Q1 (95% IC) = 2.52 (1.15-5.49)). Intakes of well-done(ORwell-donevsrare (95% CI) = 1.62 (1.15-2.30)) and stewed (OR (95% CI) = 1.49(1.20-1.84)) red meat were associated with increased BC risk, with a high riskobserved for HR+ tumours (ER+/PR+ and HER2-). Pan-fried/bread-coated fried white meat, but not doneness preference, was associated with an increased BC risk forall women (OR (95% CI) = 1.38 (1.14-1.65)), with a stronger association forpre-menopausal women (OR (95% CI) = 1.78 (1.29-2.46)).CONCLUSION: The risk of developing BC could be reduced by moderating theconsumption of well-done or stewed red meat, pan-fried/bread-coated fried whitemeat and, especially, processed/cured meat.Copyright © 2018 Elsevier B.V. All rights reserved.DOI: 10.1016/j.maturitas.2018.01.020 PMID: 29563037 